Prostatic Hyperplasia: all 803 studies

Page 7 of 9. Open to participants first (174), then studies with results posted, then the rest; newest registration first within each.

• Study to Evaluate the Effect of ALNA® (Tamsulosin) on the Primary Symptoms of Benign Prostatic HyperplasiaCompletedNCT02244268
• FLOMAX® Versus HYTRIN® in Patients With the Signs and Symptoms of Benign Prostatic HyperplasiaCompletedNCT02244255Phase 4
• Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Prostatic HyperplasiaCompletedNCT02244242Phase 4
• Study to Evaluate the Therapeutic Action of Tamsulosin and Finasteride in Symptomatic Benign Prostatic Hyperplasia (BPH) PatientsCompletedNCT02244229Phase 4
• Impact of Bladder Underactivity on Treatment Outcomes of Laser ProstatectomyStatus unknownNCT02243540
• Predictors of de Novo Urge Urinary Incontinence After Photoselective Vaporization of the ProstateStatus unknownNCT02243085
• Impact of Postoperative Pyuria on Treatment Outcomes After PVPStatus unknownNCT02241902
• Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and TamsulosinCompletedNCT02239484Phase 1
• Embozene® Microspheres for Prostatic Arterial Embolization in Patients With Symptomatic Benign Prostatic HyperplasiaCompletedNCT02206243
• Comparative Bioavailability of Two Fixed Dose Combination (FDC) Formulations of Dutasteride and Tamsulosin Hydrochloride Relative to Co-administration of Dutasteride With Tamsulosin Hydrochloride in Healthy Male Subjects Under Fed and Fasted StatesCompletedNCT02184585Phase 1
• Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and TamsulosinCompletedNCT02180997Phase 1
• A Study to Evaluate the Tolerability and Efficacy of Tamsulosin 0.4mg OCAS Formulation in Patients Who Are Unsatisfied With the Treatment of Tamsulosin 0.2mg Conventional FormulationCompletedNCT02180789Phase 4
• Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH)CompletedNCT02167919Not applicable
• Benign Prostatic Hyperplasia and Prostate Size Greater Than 90 GramsStatus unknownNCT02167009Not applicable
• Study to Assess the Efficacy of Medi-Tate iTind DeviceCompletedNCT02145208Not applicable
• PERmixon® in LUTS Evaluation Study (PERLES)CompletedNCT02121613Phase 4
• Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic HyperplasiaCompletedNCT02106182Phase 4
• KTP Green Light Prostatectomy Compared With TUR-P in High Risk PatientsActive, not recruitingNCT02075736Not applicable
• Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic HyperplasiaCompletedNCT02074644Not applicable
• Storage Symptom After Laser ProstatectomyStatus unknownNCT02073799
• KTP Green Light Prostatectomy Compared With Open ProstatectomyCompletedNCT02072499Phase 4
• Prostatic Artery Embolization vs. Conventional Transurethral Prostatectomy in the Treatment of Benign Prostatic HyperplasiaCompletedNCT02054013Not applicable
• Moxibustion as an Adjuvant for Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms: a Pilot StudyCompletedNCT02051036Not applicable
• Assessment of Prostatic Tissue Concentration of Ertapenem After a Pre-operative AdministrationCompletedNCT02041767Phase 4
• A Study to Evaluate the Efficacy and Safety of ASP4901 in Patients With Benign Prostate HyperplasiaCompletedNCT02038868Phase 2
• The Effect of Daily Tamsulosin 0.2mg Administration on Renal Function in Patients With Benign Prostatic HyperplasiaStatus unknownNCT02033798Not applicable
• Functional Changes of Urogenital System After Holmium Laser ProstatectomyStatus unknownNCT02033785
• Observational Study to Evaluate Effect of Thrupas® Capsule on Cardiovascular SystemCompletedNCT02029560
• Post-Marketing Study Using PROLIEVE® for the Treatment of Benign Prostatic Hyperplasia (BPH)Status unknownNCT02021032Phase 4
• Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization ElectrodeTerminatedNCT02019030
• Robust Evaluation to Measure Improvements in Nonadherence From Low-cost DevicesCompletedNCT02015806Not applicable
• KTP (Potassium-titanyl-phosphate) Laser Versus TUR-P (Transurethral Resection of Prostate)CompletedNCT02011308Not applicable
• Prostatic Artery Embolization Versus 532 nm Green Light PVP for Catheterized PatientsStatus unknownNCT02006303Phase 4
• Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile DysfunctionWithdrawnNCT01967251Phase 2
• Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPHCompletedNCT01966614Phase 3
• Clinical Trial to Evaluate the Efficacy and Safety of the Transarterial Supraselective Embolization of the Prostate to Treat the Urinary Symptoms.CompletedNCT01963312Not applicable
• To Compare Outcomes After Transurethral Enucleation of Prostate Versus Transurethral Resection of ProstateCompletedNCT01958892
• This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmacokinetics and Safety of Dutasteride and Tamsulosin When Administered Alone and In-combination in Chinese Healthy Male Volunteers. The Study Will Last Approximately Eleven Weeks. Blood SamplesCompletedNCT01957189Phase 1
• Plasmakinetic Enucleation of the Prostate and Open Prostatectomy to Treat Large ProstatesCompletedNCT01952912Not applicable
• Safety and Pharmacokinetic Interaction Study of Tadalafil and DutasterideCompletedNCT01942551Phase 1
• Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic HyperplasiaCompletedNCT01939184Phase 2
• Results of Selective Prostatic Arterial Embolization in Patients With Indwelling Urinary Catheter Due to Benign Prostatic Hyperplasia Refractory to Medical Treatment.TerminatedNCT01931605Phase 3
• Clinical Trial to Evaluate the Efficacy and Safety of Naftopidil in Male Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic HyperplasiaCompletedNCT01922375Phase 4
• Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (US)TerminatedNCT01896973Not applicable
• The Effective Concentration of Lidocaine With Fentanyl in Lumbar Epidural Anesthesia for Transurethral Resection of Prostate(TURP) in Elderly PatientsCompletedNCT01892332Not applicable
• 2013 Annual National Digital Rectal Exam (DRE) Day StudyCompletedNCT01886547
• Clasic Laryngeal Mask Airway(C-LMA) and I-gel Releated Regurgitation and ComplicationsStatus unknownNCT01876836Phase 4
• Low Dose Bupivacaine Spinal for Trans Uretral Prostatectomy.Status unknownNCT01861041Phase 4
• Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022)CompletedNCT01846793Phase 3
• Prostatic Artery Embolization for Benign Prostatic HyperplasiaCompletedNCT01835860Phase 2/3
• JALYN for Benign Prostatic Hyperplasia (BPH) and Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)TerminatedNCT01830829Phase 3
• PK Comparison of GL2701 With Finasteride and Tamsulosin in CombinationCompletedNCT01829893Phase 1
• Configuration of a New Prostate Disease Nomogram Predicting Prostate Biopsy OutcomeCompletedNCT01826617
• Prognostic Value of the Urinary Nerve Growth Factor in the Patients With Benign Prostatic HyperplasiaCompletedNCT01781117Not applicable
• Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (Canada)WithdrawnNCT01775488Not applicable
• WEUSKOP5723: Prostate Cancer StudyCompletedNCT01767363
• Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic HyperplasiaCompletedNCT01757769Phase 4
• Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate)CompletedNCT01747577Phase 4
• Advanced Benefits of Alpha-blocker Monotherapy on Lower Urinary Tracts Symptoms(LUTS) PatientsStatus unknownNCT01736033Phase 4
• Assessing the Impact of the PVP With Greenlight Laser Using Prostatic MRI and Contrast-enhanced UltrasoundCompletedNCT01732991Not applicable
• Addition of Lidocaine to Levobupivacaine Reduces Intrathecal Block DurationCompletedNCT01675895Phase 4
• Effective Dose of Dexmedetomidine for Sedation in Patients Undergoing TURP/TURB Under Spinal Anesthesia With or Without Fentanyl by Age Groups: Randomized Comparative StudyCompletedNCT01665586Not applicable
• Bioequivalence - Duodart Against Avodart & OmnicCompletedNCT01657851Phase 1
• Plasmakinetic Enucleation of the Prostate to Treat Benign Prostatic Hypertrophy Patients With Large ProstateCompletedNCT01637701Not applicable
• Evaluation of Finastride Effect in Different Dosage on the Amount of Perioperative Bleeding in Transurthral Resection of ProstateCompletedNCT01627522Phase 2/3
• Exploratory Study of L.S.E.S.r. (LipidoSterolic Extract of Serenoa Repens)(PERMIXON® 160 mg Hard Capsule) Versus Tamsulosine LP Activity on Inflammation Biomarkers in Urinary Symptoms Related to BPH (Benign Prostatic Hyperplasia)CompletedNCT01604811Phase 4
• Retrospective Review a Comprehensive Case Database of HoLEP Procedure Performed by a Single SurgeonCompletedNCT01604148
• Study to Compare the Bioavailability of Dutasteride Novel Formulation Form to the Soft Gel Capsule Form in Healthy Male SubjectsCompletedNCT01577693Phase 1
• Intraprostatic Botulinum Toxin Type "A" Injection in Patients With Benign Prostatic Hyperplasia and Unsatisfactory Response to Medical TherapyCompletedNCT01566292Phase 2/3
• QUAPELLA (QUAlity of Prostate Enucleation by LUMENIS - Laser)CompletedNCT01534793
• BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH)WithdrawnNCT01520441Early Phase 1
• A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East AsiaCompletedNCT01495026Phase 1
• Holmium Laser Enucleation of Prostate(HOLEP) vs Greenlight(XPS) Laser Photoselective Vapo-Enucleation of Prostate(PVEP)CompletedNCT01494337Phase 4
• The Role of microRNAs in Organ Remodeling in Lower Urinary Tract DysfunctionCompletedNCT01482676
• Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males.CompletedNCT01471678Phase 1
• Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH)CompletedNCT01454349Phase 1/2
• Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)CompletedNCT01438775Phase 3
• Assessing Safety & Efficacy of MediTate Temporary Implant in Subjects With Benign Prostate HyperplasiaCompletedNCT01436877Not applicable
• Clinical Progression and Costs in Benign Prostatic Hyperplasia Patients Treated With Early Versus Delayed Combination TherapyCompletedNCT01435954
• Effects of Tamsulosin 0.4mg on Clinical Outcomes in Korean Men With Severe Symptomatic Benign Prostatic Hyperplasia (BPH)Status unknownNCT01404637Not applicable
• A Self-Administered Maneuver to Relieve Symptoms Suggestive of Benign Prostatic HyperplasiaCompletedNCT01387893Not applicable
• Establishing the Benefits of Adherence to Enlarged Prostate Treatment: A Validation Study Linking Adherence to Outcomes Using the Market Scan DatabaseCompletedNCT01381510
• Drug Use Investigation for AVOLVE(BPH)CompletedNCT01376284
• Benefits of Adherence to 5-alpha Reductase Inhibitor Treatment in Men With Enlarged Prostate: An Assessment of Medicare and Medicaid Patients Using the MarketScan DatabaseCompletedNCT01376258
• Korean Practice Patterns for Screening PCA(Prostate Cancer)CompletedNCT01371513
• An Observational Study of Dutasteride and Alpha-blocker Combination Therapy in Men With Symptomatic Benign Prostatic Hyperplasia and PSA Level Over 4 ng/mLStatus unknownNCT01351987
• The Effects of Intrathecal Dexmedetomidine on Spinal Anesthesia Using Diluted Low-Dose Bupivacaine for Transurethral Resection of Prostate in ElderlyCompletedNCT01342562Not applicable
• Economic Analyses of the REDUCE TrialCompletedNCT01337258
• Dose Response Study of VA106483 in Males With Nocturia and Benign Prostatic Hypertrophy (BPH)CompletedNCT01330927Phase 1
• 3D Recording of a Trans-rectal Prostate BiopsyStatus unknownNCT01314456Not applicable
• Comparison Between Alpha Blocker Monotherapy and 5ARI Monotherapy Following Combination Therapy in Benign Prostatic Hyperplasia (BPH)CompletedNCT01301599Phase 4
• A-botulinic Toxin for Symptomatic Benign Prostate HypertrophyCompletedNCT01275521Phase 3
• Safety and Efficacy of QD Versus BID Silodosin With Lower Urinary Tract Symptoms Suggestive of BPHCompletedNCT01260129Phase 4
• Study of a α1A Adrenoceptor Selective Antagonist Silodosin to Treat Severe Benign Prostatic Hyperplasia(BPH)CompletedNCT01259531Phase 4
• A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry.CompletedNCT01254071Phase 1
• Effects of Alpha Blockers on Prostate-specific Antigen (PSA) Change in Men With Lower Urinary Tract Symptoms (LUTS)CompletedNCT01250483
• A Comparative Study of KSO-0400 in BPH Patients With LUTSCompletedNCT01222650Phase 2
• Efficacy And Safety Study Of Naftopidil to Patients Treatment With LUTSWithdrawnNCT01203371Phase 3
• Prostate Cancer Antigen 3 (PCA-3) Gene ProjectCompletedNCT01177436Not applicable
• Transient Urinary Incontinence After Holmium Laser Enucleation of the Prostate (HoLEP)CompletedNCT01108367

← Prostatic Hyperplasia overview